Product Code: ETC9951758 | Publication Date: Sep 2024 | Updated Date: Jan 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United Kingdom (UK) Pharmaceutical Market Overview |
3.1 United Kingdom (UK) Country Macro Economic Indicators |
3.2 United Kingdom (UK) Pharmaceutical Market Revenues & Volume, 2021 & 2031F |
3.3 United Kingdom (UK) Pharmaceutical Market - Industry Life Cycle |
3.4 United Kingdom (UK) Pharmaceutical Market - Porter's Five Forces |
3.5 United Kingdom (UK) Pharmaceutical Market Revenues & Volume Share, By Prescription Type, 2021 & 2031F |
3.6 United Kingdom (UK) Pharmaceutical Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
3.7 United Kingdom (UK) Pharmaceutical Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.8 United Kingdom (UK) Pharmaceutical Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.9 United Kingdom (UK) Pharmaceutical Market Revenues & Volume Share, By Mode of Administration, 2021 & 2031F |
3.10 United Kingdom (UK) Pharmaceutical Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 United Kingdom (UK) Pharmaceutical Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 United Kingdom (UK) Pharmaceutical Market Trends |
6 United Kingdom (UK) Pharmaceutical Market, By Types |
6.1 United Kingdom (UK) Pharmaceutical Market, By Prescription Type |
6.1.1 Overview and Analysis |
6.1.2 United Kingdom (UK) Pharmaceutical Market Revenues & Volume, By Prescription Type, 2021- 2031F |
6.1.3 United Kingdom (UK) Pharmaceutical Market Revenues & Volume, By Prescription Drugs, 2021- 2031F |
6.1.4 United Kingdom (UK) Pharmaceutical Market Revenues & Volume, By Over-the-Counter Drugs, 2021- 2031F |
6.2 United Kingdom (UK) Pharmaceutical Market, By Drug Type |
6.2.1 Overview and Analysis |
6.2.2 United Kingdom (UK) Pharmaceutical Market Revenues & Volume, By Branded Drugs, 2021- 2031F |
6.2.3 United Kingdom (UK) Pharmaceutical Market Revenues & Volume, By Generic Drugs, 2021- 2031F |
6.2.4 United Kingdom (UK) Pharmaceutical Market Revenues & Volume, By Branded Generic Drugs, 2021- 2031F |
6.3 United Kingdom (UK) Pharmaceutical Market, By Drug Class |
6.3.1 Overview and Analysis |
6.3.2 United Kingdom (UK) Pharmaceutical Market Revenues & Volume, By Small Molecules, 2021- 2031F |
6.3.3 United Kingdom (UK) Pharmaceutical Market Revenues & Volume, By Biologics, 2021- 2031F |
6.3.4 United Kingdom (UK) Pharmaceutical Market Revenues & Volume, By Biosimilars, 2021- 2031F |
6.4 United Kingdom (UK) Pharmaceutical Market, By Indication |
6.4.1 Overview and Analysis |
6.4.2 United Kingdom (UK) Pharmaceutical Market Revenues & Volume, By Cardiovascular Diseases, 2021- 2031F |
6.4.3 United Kingdom (UK) Pharmaceutical Market Revenues & Volume, By Immunology, 2021- 2031F |
6.4.4 United Kingdom (UK) Pharmaceutical Market Revenues & Volume, By Respiratory Diseases, 2021- 2031F |
6.4.5 United Kingdom (UK) Pharmaceutical Market Revenues & Volume, By Neurological Diseases, 2021- 2031F |
6.4.6 United Kingdom (UK) Pharmaceutical Market Revenues & Volume, By Infectious Diseases, 2021- 2031F |
6.4.7 United Kingdom (UK) Pharmaceutical Market Revenues & Volume, By Skin Diseases, 2021- 2031F |
6.5 United Kingdom (UK) Pharmaceutical Market, By Mode of Administration |
6.5.1 Overview and Analysis |
6.5.2 United Kingdom (UK) Pharmaceutical Market Revenues & Volume, By Topical, 2021- 2031F |
6.5.3 United Kingdom (UK) Pharmaceutical Market Revenues & Volume, By Oral, 2021- 2031F |
6.5.4 United Kingdom (UK) Pharmaceutical Market Revenues & Volume, By Injectable, 2021- 2031F |
6.5.5 United Kingdom (UK) Pharmaceutical Market Revenues & Volume, By Intra-nasal, 2021- 2031F |
6.5.6 United Kingdom (UK) Pharmaceutical Market Revenues & Volume, By Others, 2021- 2031F |
6.6 United Kingdom (UK) Pharmaceutical Market, By Distribution Channel |
6.6.1 Overview and Analysis |
6.6.2 United Kingdom (UK) Pharmaceutical Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F |
6.6.3 United Kingdom (UK) Pharmaceutical Market Revenues & Volume, By Retail Pharmacies, 2021- 2031F |
6.6.4 United Kingdom (UK) Pharmaceutical Market Revenues & Volume, By Drug Stores, 2021- 2031F |
6.6.5 United Kingdom (UK) Pharmaceutical Market Revenues & Volume, By Online Pharmacies, 2021- 2031F |
7 United Kingdom (UK) Pharmaceutical Market Import-Export Trade Statistics |
7.1 United Kingdom (UK) Pharmaceutical Market Export to Major Countries |
7.2 United Kingdom (UK) Pharmaceutical Market Imports from Major Countries |
8 United Kingdom (UK) Pharmaceutical Market Key Performance Indicators |
9 United Kingdom (UK) Pharmaceutical Market - Opportunity Assessment |
9.1 United Kingdom (UK) Pharmaceutical Market Opportunity Assessment, By Prescription Type, 2021 & 2031F |
9.2 United Kingdom (UK) Pharmaceutical Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
9.3 United Kingdom (UK) Pharmaceutical Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.4 United Kingdom (UK) Pharmaceutical Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.5 United Kingdom (UK) Pharmaceutical Market Opportunity Assessment, By Mode of Administration, 2021 & 2031F |
9.6 United Kingdom (UK) Pharmaceutical Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 United Kingdom (UK) Pharmaceutical Market - Competitive Landscape |
10.1 United Kingdom (UK) Pharmaceutical Market Revenue Share, By Companies, 2024 |
10.2 United Kingdom (UK) Pharmaceutical Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |